Abstract

Paget’s disease of bone (PDB) is characterised by focal abnormalities of bone remodelling, with increased osteoclastic resorption the primary feature of the disease. Genetic factors have been shown to play an important role in PDB, and genome-wide association studies (GWAS) have identified 7 genetic loci as associated with PDB at the genome-wide level. Expression quantitative trait locus (eQTL) studies using cell types that are directly relevant to the disease of interest are increasingly being used to identify putative effector genes for GWAS loci. We have recently constructed a unique osteoclast-specific eQTL resource using cells differentiated in vitro from 158 subjects for study of the genetics of bone disease. Considering the major role osteoclasts have in PDB, we used this resource to investigate potential genetic regulatory effects for the 7 PDB genome-wide significant loci on genes located within 500 kb of each locus. After correction for multiple testing, we observed statistically significant associations for rs4294134 with expression of the gene STMP1, and rs2458413 with expression of the genes DPYS and DCSTAMP. The eQTL associations observed for rs4294134 with STMP1, and rs2458413 with DCSTAMP were further supported by eQTL data from other tissue types. The product of the STMP1 gene has not been extensively studied, however the DCSTAMP gene has an established role in osteoclast differentiation and the associations seen between rs2458413 and PDB are likely mediated through regulatory effects on this gene. This study highlights the value of eQTL data in determining which genes are relevant to GWAS loci.

Details

Title
Genetic regulatory mechanisms in human osteoclasts suggest a role for the STMP1 and DCSTAMP genes in Paget’s disease of bone
Author
Mullin, Benjamin H 1 ; Zhu, Kun 2 ; Brown, Suzanne J 3 ; Mullin, Shelby 1 ; Tickner, Jennifer 4 ; Pavlos, Nathan J 4 ; Dudbridge, Frank 5 ; Xu Jiake 4 ; Walsh, John P 2 ; Wilson, Scott G 6 

 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942); University of Western Australia, School of Biomedical Sciences, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942); University of Western Australia, Medical School, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942) 
 University of Western Australia, School of Biomedical Sciences, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910) 
 University of Leicester, Department of Health Sciences, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411) 
 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942); University of Western Australia, School of Biomedical Sciences, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); King’s College London, Department of Twin Research & Genetic Epidemiology, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
Publication year
2019
Publication date
Jan 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2174280768
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.